Tentacles of fury
A pheromone from female squid has been identified that triggers immediate and dramatic fighting in male squid that touch it.
A pheromone from female squid has been identified that triggers immediate and dramatic fighting in male squid that touch it.
It was first observed in field studies that male long finned squid were visually attracted to eggs laid on the sea floor, and upon contact switched from calm swimming to the highest level of aggressive fighting. To identify the cause of this behaviour, the components of egg samples have been analysed and the results of this study have been published in Current Biology.1
Eggs samples had their components separated and purified using chromatography; male squid were then exposed to the results. The cause was found to be a protein pheromone, produced in the female reproductive tract and embedded in the surface of the eggs. This pheromone was found to be extremely resistant to degradation and even worked when painted onto a glass vial containing squid eggs.
Experiments showed that the first male to touch the eggs became aggressive fastest, leading to dominance by that squid. Dominant males pair with the females and mate more often, giving them greater fertilization success.
The protein, termed Loligo ß-microseminoprotein, shares similarities with other ß-microseminoproteins, also present in human semen and the secretions of other vertebrates, such as rats and boars. While the researchers say the proteins are too different to infer the same effects on vertebrates, this discovery may inspire other researchers to consider the widespread role this gene family may play in sexual competition.
1. S.F. Cummins et al., Current Biology, (In press).
This story originally appeared in The Column. Click here to view that issue.
AI and GenAI Applications to Help Optimize Purification and Yield of Antibodies From Plasma
October 31st 2024Deriving antibodies from plasma products involves several steps, typically starting from the collection of plasma and ending with the purification of the desired antibodies. These are: plasma collection; plasma pooling; fractionation; antibody purification; concentration and formulation; quality control; and packaging and storage. This process results in a purified antibody product that can be used for therapeutic purposes, diagnostic tests, or research. Each step is critical to ensure the safety, efficacy, and quality of the final product. Applications of AI/GenAI in many of these steps can significantly help in the optimization of purification and yield of the desired antibodies. Some specific use-cases are: selecting and optimizing plasma units for optimized plasma pooling; GenAI solution for enterprise search on internal knowledge portal; analysing and optimizing production batch profitability, inventory, yields; monitoring production batch key performance indicators for outlier identification; monitoring production equipment to predict maintenance events; and reducing quality control laboratory testing turnaround time.
2024 EAS Awardees Showcase Innovative Research in Analytical Science
November 20th 2024Scientists from the Massachusetts Institute of Technology, the University of Washington, and other leading institutions took the stage at the Eastern Analytical Symposium to accept awards and share insights into their research.
